Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/243699
Type: Artigo de periódico
Title: Do Genetic Polymorphisms Modulate Response Rate And Toxicity Of Cisplatin Associated With Radiotherapy In Laryngeal Squamous Cell Carcinoma? A Case Report
Author: Lopes-Aguiar
Leisa; Visacri
Marilia Berlofa; Lopes Nourani
Carolina Marques; Dias Costa
Ericka Francislaine; Silva Nogueira
Guilherme Augusto; Penna Lima
Tathiane Regine; Pincinato
Eder Carvalho; Moriel
Patricia; Carrasco Altemani
Joao Mauricio; Passos Lima
Carmen Silvia
Abstract: Cisplatin (CDDP) plus radiotherapy (RT) has been used to treat advanced laryngeal squamous cell carcinoma (LSCC) patients. Single nucleotide polymorphisms (SNPs) may be responsible for differences in chemo/radiosensitivity and side effects in those patients. We reported an advanced LSCC patient, who obtained durable complete response and unexpected pronounced toxicity during CDDP and RT, possibly due to SNPs in genes that modulate the effects of this therapeutic modality. Case presentation: A 30-year-old man with advanced LSCC obtained durable complete response and severe alopecia and pancytopenia after standard and reduced doses of CDDP and RT. Analyses of SNPs revealed that the patient presented GSTT1 deletion, variant MSH3 1045ThrThr, wild GSTP1 105IleIle, and wild BAX -248GG genotypes, which were previously described in association with abnormal detoxification, DNA repair, and damaged cell apoptosis, respectively. Seven other advanced LSCC patients with GSTT1 gene, MSH3 AlaAla or AlaThr, GSTP1 IleVal or ValVal, and BAX GA or AA genotypes served as controls of the study. Only 1 control presented complete response; the other 6 controls obtained partial response of short duration. Four and 3 controls presented grade 1 or 2 and grade 3 anemia or leukopenia during treatment, respectively. The CDDP level in urine collected after CDDP infusion in the reported patient was lower than the median value obtained in controls, suggesting a higher amount of intracellular CDDP in the reported case. The data suggest, for the first time, that inherited abnormalities in intracellular detoxification of CDDP, DNA repair of lesions induced by CDDP and RT, and damaged cell apoptosis may alter treatment response and toxicity in LSCC, but should be confirmed by large pharmacogenomic studies.
Subject: Single-nucleotide Polymorphisms
Cancer-patients
Neck-cancer
Head
Chemotherapy
Risk
Pharmacokinetics
Radiosensitivity
Platinum
Repair
Country: PHILADELPHIA
Editor: LIPPINCOTT WILLIAMS & WILKINS
Citation: Do Genetic Polymorphisms Modulate Response Rate And Toxicity Of Cisplatin Associated With Radiotherapy In Laryngeal Squamous Cell Carcinoma? A Case Report. Lippincott Williams & Wilkins, v. 94, p. APR-2015.
Rights: aberto
Identifier DOI: 10.1097/MD.0000000000000578
Address: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602693/
Date Issue: 2015
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
wos_000353794700001.pdf170.05 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.